157 related articles for article (PubMed ID: 17583131)
1. [Cutaneous lymphomas].
Bachelez H
Rev Prat; 2007 Mar; 57(5):469-75. PubMed ID: 17583131
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous malignant lymphomas: update 2006.
Burg G; Kempf W; Cozzio A; Döbbeling U; Feit J; Golling P; Michaelis S; Schärer L; Nestle F; Dummer R
J Dtsch Dermatol Ges; 2006 Nov; 4(11):914-33. PubMed ID: 17081267
[TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous B-cell lymphoma (low-grade, non large cell).
Moore MM; Kovich OI; Brown LH
Dermatol Online J; 2007 Jan; 13(1):8. PubMed ID: 17511941
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous lymphomas.
Dummer R; Stadler R; Sterry W
J Dtsch Dermatol Ges; 2007 Jul; 5(7):605-17. PubMed ID: 17610612
[TBL] [Abstract][Full Text] [Related]
6. The applicability of the new WHO-EORTC classification of primary cutaneous lymphomas to a single referral center.
Khamaysi Z; Ben-Arieh Y; Izhak OB; Epelbaum R; Dann EJ; Bergman R
Am J Dermatopathol; 2008 Feb; 30(1):37-44. PubMed ID: 18212543
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous lymphomas showing prominent granulomatous component: clinicopathological features in a series of 16 cases.
Gallardo F; García-Muret MP; Servitje O; Estrach T; Bielsa I; Salar A; Abella E; Barranco C; Pujol RM
J Eur Acad Dermatol Venereol; 2009 Jun; 23(6):639-47. PubMed ID: 19207677
[TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous marginal zone lymphoma.
Dalle S; Thomas L; Balme B; Dumontet C; Thieblemont C
Crit Rev Oncol Hematol; 2010 Jun; 74(3):156-62. PubMed ID: 19819717
[TBL] [Abstract][Full Text] [Related]
9. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J
J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274
[TBL] [Abstract][Full Text] [Related]
10. [Cutaneous follicular center B-cell lymphoma treated with intralesional rituximab].
Gamo R; Calzado L; Pinedo F; López-Estebaranz JL
Actas Dermosifiliogr; 2008 May; 99(4):291-6. PubMed ID: 18394405
[TBL] [Abstract][Full Text] [Related]
11. Hyperplasia of hair follicles and other adnexal structures in cutaneous lymphoproliferative disorders: a study of 53 cases, including so-called pseudolymphomatous folliculitis and overt lymphomas.
Kazakov DV; Belousova IE; Kacerovska D; Sima R; Vanecek T; Vazmitel M; Pizinger K; Michal M
Am J Surg Pathol; 2008 Oct; 32(10):1468-78. PubMed ID: 18685486
[TBL] [Abstract][Full Text] [Related]
12. [Primary centrocytic lymphoma of the skin: diagnosis, course and therapy (author's transl)].
Schultz-Ehrenburg U; Lämmer D
Dermatologica; 1981; 162(5):350-61. PubMed ID: 7250469
[TBL] [Abstract][Full Text] [Related]
13. The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system used by the Dutch Cutaneous Lymphoma Group.
Senff NJ; Willemze R
Br J Dermatol; 2007 Dec; 157(6):1205-11. PubMed ID: 17941944
[TBL] [Abstract][Full Text] [Related]
14. [Current approaches to diagnosing and treating primary cutaneous lymphomas on the basis of a new WHO-EORTC classification, cutaneous T-cell lymphomas].
Belousova IE; Kazakov DV; Krivolapov IuA
Arkh Patol; 2007; 69(5):11-7. PubMed ID: 18074813
[TBL] [Abstract][Full Text] [Related]
15. The spectrum of peripheral T-cell lymphomas.
O'leary H; Savage KJ
Curr Opin Hematol; 2009 Jul; 16(4):292-8. PubMed ID: 19509496
[TBL] [Abstract][Full Text] [Related]
16. Future perspectives in the treatment of cutaneous T-cell lymphoma (CTCL).
Dummer R
Semin Oncol; 2006 Feb; 33(1 Suppl 3):S33-6. PubMed ID: 16516674
[TBL] [Abstract][Full Text] [Related]
17. Fatal subcutaneous panniculitis-like T-cell lymphoma gamma/delta subtype (cutaneous gamma/delta T-cell lymphoma): report of a case and review of the literature.
Kao GF; Resh B; McMahon C; Gojo I; Sun CC; Phillips D; Zhao XF
Am J Dermatopathol; 2008 Dec; 30(6):593-9. PubMed ID: 19033937
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous marginal zone B-cell lymphoma: clinical and histological aspects.
Khaled A; Sassi S; Fazaa B; Ben Hassouna J; Ben Romdhane K; Kamoun MR
Pathologica; 2009 Feb; 101(1):18-20. PubMed ID: 19771768
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis and therapy of cutaneous lymphomas--progress or impasse?
Dummer R; Cozzio A; Urosevic M
Exp Dermatol; 2006 May; 15(5):392-400. PubMed ID: 16630081
[TBL] [Abstract][Full Text] [Related]
20. Standard and experimental therapy in cutaneous T-cell lymphomas.
Dummer R; Cozzio A; Meier S; Beyeler M; Laetsch B; Doebbeling U; Urosevic M
J Cutan Pathol; 2006 Feb; 33 Suppl 1():52-7. PubMed ID: 16412213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
